Major complications following exenteration in cases of pelvic malignancy: A 10-year experience

Table 1 Clinical characteristics of patients

Patient number	Age(yr)	Year of operation	Days inhospitalafter surgery	Histology	Method	Blood transfusion (mL)	Operating time(min)	Complications
1	59	1996	48	vulvar - scc	PPE	240	240	wd
2	48	1996	14	vulvar - scc	PPE	800	315	-
3	62	1998	35	vulvar - scc	PPE	600	330	urinary infection, wd
4	77	1998	28	vulvar - scc	PPE	900	360	-
5	37	1998	15	rectal-adenoca	PPE	600	255	-
6	50	1999	23	ovarian-adenoca	PPE	1200	405	-
7	65	2000	54	vulvar - scc	PPE	1500	380	urinary infection, wd
8	34	2000	49	vulvar - scc	TPE	1200	330	ARDS, wd
9	52	2000	16	vulvar - scc	PPE	300	360	urinary incontinence
10	44	2000	-	uterine sarcoma	PPE	1800	275	massive bleeding- died during operation
11	43	2002	28	vulvar - scc	PPE	1560	350	-
12	64	2002	28	vulvar - scc	PPE	900	420	-
13	63	2002	42	vulvar - scc	TPE	1420	450	thrombophlebitis, wd
14	53	2002	25	Bartholin’s gland -scc	PPE	1100	360	urinary infection, wd
15	44	2002	41	vulvar - scc	PPE	1500	450	ureter damage, wd
16	64	2002	14	rectal-adenoca	PPE	300	315	-
17	62	2002	16	cervical - scc	PPE	500	360	-
18	57	2003	28	vulvar - scc	PPE	3580	420	massive bleeding
19	34	2003	24	cervical - scc	APE	1285	480	acute renal failure
20	34	2003	8	rectal-adenoca	PPE	280	380	-
21	74	2004	66	vulvar - scc	PPE	500	330	wd, urinary incontinence
22	82	2004	16	rectal-adenoca	PPE	950	330	-
23	53	2004	10	cervical scc	APE	1200	410	pulmonary embolism- death
24	48	2005	15	rectal-adenoca	PPE	900	435	-
25	43	2005	14	cervical- adenoca	TPE	1500	660	wd, bleeding- reoperation
26	56	2005	29	rectal-adenoca	PPE	1200	705	urinary bladder disfunction
27	51	2005	26	cervical scc	PPE	1200	560	urinary fistula
28	38	2005	10	cervical scc	TPE	1800	430	-
Mean	53.3	-	26.7	-	-	1100	396	-

Wd = wound dehiscence; ARDS = adult respiratory distress syndrome; SCC = squamous cell carcinoma